Announced
Synopsis
Pfizer, an American multinational pharmaceutical and biotechnology corporation, agreed to acquire manufacturing facility in Sanford of Abzena, a provider of services and technologies for the selection, development, and manufacture of biopharmaceutical products. Financial terms were not disclosed. “We’re thrilled to announce this agreement with Pfizer. I am very proud of the facility and our colleagues who worked tirelessly in its construction, and we look forward to building our future collaboration with Pfizer,” Matt Stober, Abzena CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.